Impressive Vertex hepatitis C drug data unveiled
November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.
Insurers, Medicaid fear multibillion-dollar hepatitis C drug tab
March 5, 2014 — (Reuters) - U.S. health insurers are seeking help from state
health officials to foot the bill for a new generation of
hepatitis C treatments that could cost the nation $200 billion
or more in the next five years.
China says child deaths not linked to hepatitis vaccine
January 3, 2014 — BEIJING (Reuters) - Chinese health authorities said they
have found no link between a hepatitis B vaccine and the deaths
of nine children who had received those shots, state media said
Indigenous hepatitis E virus on the rise in England and Wales
December 27, 2013 — NEW YORK (Reuters Health) - A new group of genotype 3
hepatitis E viruses (HEV) accounts for the sudden rise in
indigenously acquired cases in England and Wales since 2010,
Select news items provided by Reuters Health